Literature DB >> 19331814

New function of the proline rich domain in dynamin-2 to negatively regulate its interaction with microtubules in mammalian cells.

Kozue Hamao1, Makiko Morita, Hiroshi Hosoya.   

Abstract

Microtubule reorganization is necessary for many cellular functions such as cell migration, cell polarity and cell division. Dynamin was originally identified as a microtubule-binding protein. Previous limited digestion experiment revealed that C-terminal 100-amino acids proline rich domain (PRD) of dynamin is responsible for microtubule binding in vitro. However, as obvious localization of dynamin along microtubules is only observed at the spindle midzone during mitosis but not in interphase cells, it remains unclear how dynamin interacts with microtubules in vivo. Here, we report that GFP-dynamin-2-(1-786), a truncated mutant lacking a C-terminal portion of the PRD, localized along microtubules in interphase HeLa cells. GFP-dynamin-2-wild type (WT) and GFP-dynamin-2-(1-745), a construct that was further truncated to remove the entire PRD, localized in discrete punctate structures but not along microtubules. These data suggest that the N-terminal (residues 746-786) but not the entire PRD is necessary for the interaction of dynamin-2 with microtubules in the cell and that the C-terminus of PRD (787-870) negatively regulate this interaction. Microtubules in cells expressing GFP-dynamin-2-(1-786) were stabilized against exposure to cold. These results provide a first evidence for a regulated interaction of dynamin-2 with microtubules in cultured mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19331814     DOI: 10.1016/j.yexcr.2009.01.025

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  11 in total

Review 1.  The emerging role of Arf/Arl small GTPases in cilia and ciliopathies.

Authors:  Yujie Li; Kun Ling; Jinghua Hu
Journal:  J Cell Biochem       Date:  2012-07       Impact factor: 4.429

2.  Common membrane trafficking defects of disease-associated dynamin 2 mutations.

Authors:  Ya-Wen Liu; Vasyl Lukiyanchuk; Sandra L Schmid
Journal:  Traffic       Date:  2011-08-05       Impact factor: 6.215

Review 3.  Dynamin 2 and human diseases.

Authors:  Anne-Cécile Durieux; Bernard Prudhon; Pascale Guicheney; Marc Bitoun
Journal:  J Mol Med (Berl)       Date:  2010-02-03       Impact factor: 4.599

4.  The small GTPases ARL-13 and ARL-3 coordinate intraflagellar transport and ciliogenesis.

Authors:  Yujie Li; Qing Wei; Yuxia Zhang; Kun Ling; Jinghua Hu
Journal:  J Cell Biol       Date:  2010-06-07       Impact factor: 10.539

5.  Impact of dynamin 2 on adenovirus nuclear entry.

Authors:  Ji Sun Lee; Ashrafali M Ismail; Jeong Yoon Lee; Xiaohong Zhou; Emma C Materne; James Chodosh; Jaya Rajaiya
Journal:  Virology       Date:  2019-01-10       Impact factor: 3.616

Review 6.  Charcot-Marie-Tooth disease and intracellular traffic.

Authors:  Cecilia Bucci; Oddmund Bakke; Cinzia Progida
Journal:  Prog Neurobiol       Date:  2012-03-22       Impact factor: 11.685

7.  Mild functional differences of dynamin 2 mutations associated to centronuclear myopathy and Charcot-Marie Tooth peripheral neuropathy.

Authors:  Olga S Koutsopoulos; Catherine Koch; Valerie Tosch; Johann Böhm; Kathryn N North; Jocelyn Laporte
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

8.  The significance of dynamin 2 expression for prostate cancer progression, prognostication, and therapeutic targeting.

Authors:  Bin Xu; Liang Hong Teng; Sabrina Daniela da Silva; Krikor Bijian; Samir Al Bashir; Su Jie; Michael Dolph; Moulay A Alaoui-Jamali; Tarek A Bismar
Journal:  Cancer Med       Date:  2013-12-18       Impact factor: 4.452

9.  Dynamin2 organizes lamellipodial actin networks to orchestrate lamellar actomyosin.

Authors:  Manisha Menon; Olga L Askinazi; Dorothy A Schafer
Journal:  PLoS One       Date:  2014-04-07       Impact factor: 3.240

Review 10.  Dynamin-2 function and dysfunction along the secretory pathway.

Authors:  Arlek M González-Jamett; Fanny Momboisse; Valentina Haro-Acuña; Jorge A Bevilacqua; Pablo Caviedes; Ana María Cárdenas
Journal:  Front Endocrinol (Lausanne)       Date:  2013-09-18       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.